The Latest Enorama Pharma News

Latest news posts

News 07/19/2019
Enorama has submitted the proposed supplements on the MAA to the Swedish MPA
Enorama Pharma announces that proposed supplements to the Marketing Authorization Application (MAA) for each of the Company's four...
News 07/09/2019
Enorama Pharma's pathway towards a medical cannabis chewing gum
The potential market for medical cannabis is huge. Enorama Pharma's management believes that there will be a great need for serious...
News 06/02/2019
Trump administration strips India of special trade status
This decision does not affect Enorama Pharma's ongoing development work of nicotine gum for Dr. Reddy's and the North American market -...
News 05/10/2019
The Greece market for smoking cessation products is growing
Greece, with its 11 million inhabitants, has one of Europe's highest number of smokers and struggles with the public health effects of...
News 05/07/2019
New elections are proposed to the Board of Enorama Pharma: Bengt Jönsson and Anders Dahlin
On February 6 2019, Enorama Pharma decided to appoint a Nomination Committee to prepare the next Annual General Meeting's resolutions on...
News 05/06/2019
Enorama initiates collaboration with cannabis expert Dr. Arno Hazekamp
Enorama Pharma initiates a collaboration with Dr. Arno Hazekamp to benefit from his expertise within cannabis. Arno advices Enorama's...
News 05/02/2019
Enorama Pharma participates at the European Cannabis Symposium May 6 2019, Copenhagen
MJBizDaily’s European Cannabis Symposium gathers leaders in the business, research and legislation of Europe’s medical cannabis markets...
News 04/25/2019
Oral nicotine products provide safer distribution of nicotine
Enorama's new unit for nicotine products, non-pharmaceuticals, works with nicotine distributed in the oral cavity.

All news posts

Enorama Pharma submitted requested additions on its MAA to the Swedish MPA

Additions sent in four weeks before schedule.

Enorama Pharma establishes a laboratory for medical cannabis

The lab will continue the very promising project and implement prototype development of a medical cannabis chewing gum.

Enorama Pharma enters into agreements regarding screening study within Cough & Cold

The cost of this initial analysis is covered by MediiGum LLC.

Enorama Pharmas preferential rights issue oversubscribed

A few days after the announcement, we would like to reflect on the strong outcome and the great interest.

Enorama Pharma receives permission to handle cannabis

The permit allows the company to begin the work of developing a medical cannabis chewing gum.

Enorama receives wholesale license from the Swedish MPA

Enorama Pharma now has all the approvals required to apply for registration of medical products in Europe.

Wholesale license application at the Swedish MPA

Enorama Pharma AB announces that the Company has applied for a wholesale license at the Swedish Medical Products Agency (MPA) and the inspection date is set to July 24th.

BioStock: Today we celebrate "World No Tobacco Day"

World Health Organization WHO estimates that there are about 1 billion smokers in the world.

Latest news posts

Enorama has submitted the proposed supplements on the MAA to the Swedish MPA

Enorama Pharma's pathway towards a medical cannabis chewing gum

Trump administration strips India of special trade status

The Greece market for smoking cessation products is growing

New elections are proposed to the Board of Enorama Pharma: Bengt Jönsson and Anders Dahlin

Enorama initiates collaboration with cannabis expert Dr. Arno Hazekamp

Enorama Pharma participates at the European Cannabis Symposium May 6 2019, Copenhagen

Oral nicotine products provide safer distribution of nicotine